These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 34087161)

  • 21. Neuromuscular disease modeling on a chip.
    Santoso JW; McCain ML
    Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32817118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies.
    Heydari Z; Najimi M; Mirzaei H; Shpichka A; Ruoss M; Farzaneh Z; Montazeri L; Piryaei A; Timashev P; Gramignoli R; Nussler A; Baharvand H; Vosough M
    Cells; 2020 Jan; 9(2):. PubMed ID: 32012725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Engineered models of the human heart: Directions and challenges.
    Stein JM; Mummery CL; Bellin M
    Stem Cell Reports; 2021 Sep; 16(9):2049-2057. PubMed ID: 33338434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regenerative medicine, organ bioengineering and transplantation.
    Edgar L; Pu T; Porter B; Aziz JM; La Pointe C; Asthana A; Orlando G
    Br J Surg; 2020 Jun; 107(7):793-800. PubMed ID: 32463143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A decade of progress in liver regenerative medicine.
    Zhang J; Zhao X; Liang L; Li J; Demirci U; Wang S
    Biomaterials; 2018 Mar; 157():161-176. PubMed ID: 29274550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular organs-on-chip made with patient-derived endothelial cells: technologies to transform drug discovery and disease modeling.
    Whitworth CP; Polacheck WJ
    Expert Opin Drug Discov; 2024 Mar; 19(3):339-351. PubMed ID: 38117223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induced pluripotent stem cells for regenerative medicine.
    Hirschi KK; Li S; Roy K
    Annu Rev Biomed Eng; 2014 Jul; 16():277-94. PubMed ID: 24905879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut bioengineering strategies for regenerative medicine.
    O'Neill JD; Pinezich MR; Guenthart BA; Vunjak-Novakovic G
    Am J Physiol Gastrointest Liver Physiol; 2021 Jan; 320(1):G1-G11. PubMed ID: 33174453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An ultrathin membrane mediates tissue-specific morphogenesis and barrier function in a human kidney chip.
    Mou X; Shah J; Roye Y; Du C; Musah S
    Sci Adv; 2024 Jun; 10(23):eadn2689. PubMed ID: 38838141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
    Watson DE; Hunziker R; Wikswo JP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thermally-triggered fabrication of cell sheets for tissue engineering and regenerative medicine.
    Takahashi H; Okano T
    Adv Drug Deliv Rev; 2019 Jan; 138():276-292. PubMed ID: 30639258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac cell sheet engineering for regenerative medicine and tissue modeling.
    Matsuura K; Shimizu T
    Prog Mol Biol Transl Sci; 2023; 199():179-197. PubMed ID: 37678971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineered tissue grafts: opportunities and challenges in regenerative medicine.
    Feinberg AW
    Wiley Interdiscip Rev Syst Biol Med; 2012; 4(2):207-20. PubMed ID: 22012681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of human organs in pigs via interspecies blastocyst complementation.
    Wu J; Platero Luengo A; Gil MA; Suzuki K; Cuello C; Morales Valencia M; Parrilla I; Martinez CA; Nohalez A; Roca J; Martinez EA; Izpisua Belmonte JC
    Reprod Domest Anim; 2016 Oct; 51 Suppl 2():18-24. PubMed ID: 27762052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress and potential for regenerative medicine.
    Gurtner GC; Callaghan MJ; Longaker MT
    Annu Rev Med; 2007; 58():299-312. PubMed ID: 17076602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induced Pluripotent Stem Cells in Disease Modelling and Regeneration.
    Talug B; Tokcaer-Keskin Z
    Adv Exp Med Biol; 2019; 1144():91-99. PubMed ID: 30414069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic Engineering: Organoids Meet Organs-on-a-Chip.
    Takebe T; Zhang B; Radisic M
    Cell Stem Cell; 2017 Sep; 21(3):297-300. PubMed ID: 28886364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Induced Pluripotent Stem Cells in Bone Repair and Regeneration.
    Rana D; Kumar S; Webster TJ; Ramalingam M
    Curr Osteoporos Rep; 2019 Aug; 17(4):226-234. PubMed ID: 31256323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.
    Tzatzalos E; Abilez OJ; Shukla P; Wu JC
    Adv Drug Deliv Rev; 2016 Jan; 96():234-244. PubMed ID: 26428619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.